Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

7680663800020 CH-66380 Konzentrat
Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Bavencio 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/10/2025
Summary of Product Characteristics
Français
08/10/2025
Summary of Product Characteristics
Italien
08/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.725 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3139.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2021

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
66380
Drug name
Bavencio, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
L01FF04
Authorization status
Z
Dispensing category
A
First authorization
05/09/2017
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Merkelzellkarzinom, Urothelkarzinom

Package details

Description (FR)
BAVENCIO conc perf 200 mg/10ml 4 flac 10 ml
Description (DE)
BAVENCIO Inf Konz 200 mg/10ml 4 Durchstf 10 ml
Market launch
05/09/2017
Narcotic (BTM)
No

Other package sizes (1)

BAVENCIO conc perf 200 mg/10ml flac 10 ml
1 DUR
GTIN: 7680663800013
View